Basic fibroblast growth factor mediated growth inhibition in breast cancer cells is independent of ras signaling pathway

Oncology Reports

Volumn 9, Issue 4, 2002, Pages 875-877

  Fenig, Eyal ^a   Szyper Kravitz, Martin ^a,b   Yerushalmi, Rinat ^a   Lahav, Meir ^a,b   Beery, Einat ^a,b   Wasserman, Lina ^a,b   Gutman, Haim ^a   Nordenberg, Jardena ^a,b  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Basic fibroblast growth factor; Breast cancer; Lovastatin; P21 WAF1 cip1

Indexed keywords

ANTINEOPLASTIC AGENT; CDKN1A PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLINE; FARNESYL TRANS TRANSFERASE; FIBROBLAST GROWTH FACTOR 2; MEVINOLIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN P21; TRANSFERASE;

ARTICLE; BREAST TUMOR; CELL CULTURE; CELL DIVISION; DRUG ANTAGONISM; DRUG COMBINATION; DRUG EFFECT; FEMALE; HUMAN; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ALKYL AND ARYL TRANSFERASES; ANTINEOPLASTIC AGENTS; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL DIVISION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DRUG THERAPY, COMBINATION; FARNESYLTRANSTRANSFERASE; FEMALE; FIBROBLAST GROWTH FACTOR 2; HUMANS; LOVASTATIN; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; ONCOGENE PROTEIN P21(RAS); SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

EID: 0036632316     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.9.4.875     Document Type: Article

References (15)

1. Rifkin DB and Moscatelli D: Recent developments in the cell biology of basic fibroblast growth factor. J Cell Biol 109: 1-6, 1989. (Pubitemid 19180114)
2. Givol D and Yayon A: Complexity of FGF receptors: genetic basis for structural diversities and functional specificity. FASEB J 6: 3362-3369, 1992. (Pubitemid 23007101)
3. Briozzo P, Badet J, Capony F, Peiri I, Montcourrier P, Barritalt D and Rochefort H: MCF7 mammary cancer cells respond to bFGF and internalize it following its release from extracellular matrix: a permissive role of cathepsin D. Exp Cell Res 194: 252-259, 1991. (Pubitemid 121006277)
4. Karey KP and Sirbasku DA: Differential responsiveness of human breast cancer cell lines MCF-7 and T47D to growth factors and 17β-estradiol. Cancer Res 48: 4083-4092, 1988.
5. McLeskey SW, Ding IYF, Lippman ME and FG: MDA-MB-134 breast carcinoma cells overexpressed fibroblast growth factor (FGF) receptors and are growth-inhibited by FGF ligands. Cancer Res 54: 523-530, 1994.
6. Fenig E, Wieder R, Paglin S, Wang H, Persaud R, Haimovitz-Friedman A, Fuks Z and Yahalom J: Basic fibroblast growth factor confer growth inhibition and ERK activation in human breast cancer cells. Clin Cancer Res 3: 135-142, 1997. (Pubitemid 27079456)
7. Wang H, Rubin M, Fenig E, DeLasio A, Mendelson J, Yahalom J and Wieder R: Basic fibroblast growth factor causes growth arrest in MCF-7 human breast cancer cells while inducing both mitogenic and inhibitory GI events. Cancer Res 57: 1750-1751, 1997.
8. Fenig E, Livnat T, Sharkon-Polak S, Wasserman L, Beery E, Lilling G, Yahalom J, Wieder R and Nordenberg J: Basic fibroblast growth factor potentiates cisplatinum-induced cytotoxicity in MCF-7 human breast cancer cells. J Cancer Res Clin Oncol 125: 556-562, 1999. (Pubitemid 29434880)
9. Wang JK, Gao G and Goldfarb M: Fibroblast growth factor receptors have different signaling and mitogenic potentials. Mol Cell Biol 14: 181-188, 1994.
10. Sebti SM, Tkalcevic GT and Jani JP: Lovastatin, a cholesterol biosynthesis inhibitor, inhibits the growth of human H-ras oncogene transformed cells in nude mice. Cancer Commun 3: 141-147, 1991.
11. Qian Y, Sebti SM and Hamilton AD: Farnesyltransferase as a target for anticancer drug design. Biopolymers 43: 25-41, 1997. (Pubitemid 127570809)
12. Skehan P, Sotreng R, Scudigro D, Monks A, McMahon J, Vistica D, Warren JT, Bohesch H, Kenney S and Boyd MR: New colorimetric cytotoxicity assay for anticancer drug screening. J Natl Cancer Inst 82: 1107-1112, 1990. (Pubitemid 20213250)
13. Paris S and Pouyssegur J: Mitogenic effects of fibroblast growth factors in cultured fibroblasts. Interaction with the G-protein-mediated signaling pathways (Review). Ann N Y Acad Sci 638: 139-148, 1991.
14. Kivinen L and Laiho M: Ras- and mitogen-activated protein kinase kinase-dependent and -independent pathways in p11Cip1/Waf1 induction by fibroblast growth factor-2, platelet-derived growth factor, and transforming growth factor-beta 1. Cell Growth Differ 10: 621-628, 1999. (Pubitemid 29455726)
15. Vincent TS, Wulfert E and Merler E: Inhibition of growth factor signaling pathways by lovastatin. Biochem Biophys Res Commun 180: 1284-1289, 1991.